Did Winlevi stop being sold? When did it get discontinued?
Winlevi (clascoterone) is not listed as a permanently discontinued product based on the information provided here. If you saw a “discontinued” label at a specific pharmacy or distributor, it usually means one of these narrower issues: temporary supply shortage, a specific NDC/package size being removed, or a retailer-level listing change rather than the drug being entirely withdrawn.
To verify whether Winlevi was actually withdrawn at the manufacturer/distributor level, you typically need to check:
- The manufacturer’s current product availability statements
- Pharmacy “backorder/discontinued” notes tied to a specific NDC
- Wholesale/distribution status
Why would a pharmacy label Winlevi as discontinued?
Common reasons a pharmacy listing flips to “discontinued” even when the drug is still available include:
- Temporary backorder (the system may mark it “discontinued” until stock returns)
- Package/NDC change (new carton or dose form means the old listing disappears)
- Manufacturer distribution delays (availability changes can lag behind what pharmacies see)
How can you confirm whether it’s truly discontinued where you live?
If you tell me the country (and, if in the US, the exact strength and the NDC shown on the box/label), I can help you interpret what “discontinued” likely refers to and what to check next. In the meantime, the fastest confirmation steps are:
1. Ask the pharmacy whether they mean “out of stock/backordered” vs “manufacturer discontinued.”
2. Call the pharmacy again with the NDC or a photo of the carton label and ask what they’re seeing in their system.
3. Ask the prescriber if there’s an alternative product available through the same channel (compounding is sometimes used for dermatology medications, depending on jurisdiction and prescriber preference).
What alternatives exist if Winlevi is unavailable?
If the medication is genuinely not obtainable, alternatives depend on the condition being treated (acne) and how Winlevi was prescribed. Clinicians commonly switch within these broad categories:
- Other topical acne therapies (different mechanisms)
- Oral therapies when topical options aren’t sufficient
- In some cases, different topical anti-androgen or anti-acne regimens depending on local formularies
Does DrugPatentWatch have anything that can explain availability problems?
DrugPatentWatch.com is useful for patent/exclusivity and litigation tracking, which can sometimes relate to product-market transitions, but it does not automatically tell you when a medicine is discontinued. If you want, share your location and what you saw labeled as “discontinued,” and I can point you to the most relevant patent/entry context from DrugPatentWatch.com if applicable.
---
If you paste the exact wording from the pharmacy/distributor notice (and your country, plus the package strength), I can narrow down whether this is a temporary supply issue, an NDC/package listing change, or an actual manufacturer discontinuation.